Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

674625.pdf (300.09 KB)

Document type

Article

Version

Published version

Publication date

2017-11-28

Publication license

cc-by (c) Navarro Brugal, Gemma et al., 2017
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/138563

The epigenetic Cytocrin pathway to the nucleus. Epigenetic factors, epigenetic mediators, and epigenetic traits. A biochemist perspective.

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.3389/fgene.2017.00179

Abstract

A single word, Epigenetics, underlies one exciting subject in today's Science, with different sides and with interactions with philosophy. The apparent trivial description includes everything in between genotype and phenotype that occurs for a given unique DNA sequence/genome. This Perspective article first presents an historical overview and the reasons for the lack of consensus in the field, which derives from different interpretations of the diverse operative definitions of Epigenetics. In an attempt to reconcile the different views, we propose a novel concept, the "cytocrin system." Secondly, the article questions the inheritability requirement and makes emphasis in the epigenetic mechanisms, known or to be discovered, that provide hope for combating human diseases. Hopes in cancer are at present in deep need of deciphering mechanisms to support ad hoc therapeutic approaches. Better perspectives are for diseases of the central nervous system, in particular to combat neurodegeneration and/or cognitive deficits in Alzheimer's disease. Neurons are post-mitotic cells and, therefore, epigenetic targets to prevent neurodegeneration should operate in non-dividing diseased cells. Accordingly, epigenetic-based human therapy may not need to count much on transmissible potential. Keywords: nucleocrin, thermodynamics, state variables, inheritability, therapy, Alzheimer's disease, cancer, tumor therapy

Subject

Epigenètica, Expressió gènica, Genètica bioquímica

Subject (English)

Epigenetics, Gene expression, Biochemical genetics

Citation

Collections

Articles publicats en revistes (Bioquímica i Fisiologia)
Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Citation

NAVARRO BRUGAL, Gemma, et al. The epigenetic Cytocrin pathway to the nucleus. Epigenetic factors, epigenetic mediators, and epigenetic traits. A biochemist perspective. Frontiers In Genetics. 2017. Vol. 8:179, num. 1-7. ISSN 1664-8021. [consulted: 16 of August of 2026]. Available at: https://hdl.handle.net/2445/138563

Export metadata

JSON - METS

Share record